Janssen Search
Search results
Dapo Ajayi
DAPO AJAYI VICE PRESIDENT JANSSEN SUPPLY CHAIN Dapo Ajayi is Vice President, Janssen Supply Chain at Johnson & Johnson (J&J). In this role, Dapo is responsible for the global, end-to-end manufacturing and supply management of J&J ...
Tom Mickelson
TOM MICKELSON Vice President Global Therapeutic Area Leader Dermatology & Rheumatology Tom Mickelson is Vice President, Dermatology & Rheumatology Global Therapeutic Area Leader at Janssen Research & Development, LLC. In this role, he leads ...
New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
Sep 15, 2024 Spain Investigational TAR-200 monotherapy demonstrates high complete response rate without the need for reinduction or additive therapy in patients who are Bacillus Calmette-Guérin (BCG)-unresponsive BARCELONA, September 15, 2024 /PR Newswire ...
Precision Medicine and Co-Diagnostics
About the Precision Medicine Model Partners in Precision Medicine Precision Medicine Glossary About the Precision Medicine Model Partner with Us We are committed to partnering with those whose innovative thinking will bring new and creative solutions to ...
About Us
Our Story COVID-19 News Redirect Tile Our Credo Our Leadership Access and Pricing Principles The Patients Are Waiting – Paul Janssen ART GALLERY Leadership Perspectives --> Our Recognition We are honored to receive awards and recognition for our ...
Sean Larkin, MBA
Sean Larkin, MBA is responsible for developing and executing the end-to-end strategy for the Disease Area Stronghold focused on inflammatory bowel disease. In this role, he leads all new product commercialization activities, portfolio evaluations, ...
Microbiome Discovery and Development Congress
The inaugural Microbiome Discovery and Development Congress to be held in Berlin, Germany. This congress will bring together key opinion leaders and senior industry experts in microbiome drug discovery to discuss the latest innovative discovery strategies ...
Patient Engagement
Martin Freeman, Untitled Working Together Toward Patient-Inspired Innovation Patient Engagement Leadership Team Clinical Trials Finder Link Compassionate Use and Pre-Approval Access Link Interactions with Patient Organizations Link- Our Work with Patient ...
Additional Neuroscience Focuses
Other Focus Areas Janssen is also interested in pursuing external licensing opportunities in other complementary disease areas within neurodegeneration and neuroplasticity, niche indications and orphan drugs. Opportunities of interest in this area include ...
Sustainability
Our Commitment to Climate Action Products and Packaging Green Chemistry and Technology Tackling the World's Most Urgent Healthcare Needs 4 Questions About the Health Impacts of Climate Change Geothermal Energy: Ecological Innovation How Johnson & ...